Evaluation of new Forcefield technology: Reducing platelet adhesion and cell coverage of pyrolytic carbon surfaces  Mark S. Slaughter, MD, Brian Pederson,

Slides:



Advertisements
Similar presentations
Of mice and men and surgical transcatheter aortic valve insertion
Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Manuel J. Antunes, MD, PhD, DSc 
Stephen R. Broderick, MD, MPHS 
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
Ground glass opacity of the lung: The veil that needs lifting
Right internal thoracic artery or saphenous vein grafting
Intrinsic cardiac stem cells are essential for regeneration
Abracadabra I, II…HeartMate 3?
Form ever follows function
Victor van Berkel, MD, PhD 
William M. DeCampli, MD, PhD 
Skinning the cat: Another wrinkle for T-tube insertion
Multilevel data analysis: What? Why? How?
How should we treat air leaks?
Go on-pump or off-pump in diabetic patients?
The lord of the rings  Antonio Miceli, MD, PhD 
Gastric conduit revision after esophagectomy: The raising of Lazarus
The variability of the mitral valve anatomy and terminology
Intra-aortic balloon pumps and continuous flow left ventricular assist devices: Don't let balloon pumps overstay their welcome  Kevin G. Soucy, PhD, Steven.
Support Your Specialty
Innovation and science: The future of valve design
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Fixing the supply problem
Michele Gallo, MD, Gino Gerosa, MD 
Military surgeons just want to have fun
A first start for lung transplantation?
Stephen R. Broderick, MD, MPHS 
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Choice of second pericardial drainage tube for posterior placement
A case of chest wall angiosarcoma associated with breast implants
Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD 
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Replicating the success of mitral valve repair in the aortic valve
Instrumental variable methods in clinical research
Attachment disorder in thoracoabdominal surgery
Cardiac surgery in patients with a porcelain aorta
The Ross procedure: Time to reevaluate the guidelines
We are the company we keep: The importance of the tumor microenvironment  Sai Yendamuri, MD, FACS  The Journal of Thoracic and Cardiovascular Surgery 
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Biomaterials for heart valve replacement: Conjectures and refutations
Functional tricuspid pathology: To treat or not to treat
Ralph S. Mosca, MD  The Journal of Thoracic and Cardiovascular Surgery 
The harder one looks, the more one finds
First nights, the adrenal axis, and steroids
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Ventricular assistant in restrictive cardiomyopathy: Making the right connection  Robert D.B. Jaquiss, MD  The Journal of Thoracic and Cardiovascular Surgery 
The continuing challenge of congenital heart disease in China
When should the elephant (frozen elephant trunk) enter the room (aorta)?  Frank A. Baciewicz, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume.
“The more things change…”: The challenges ahead
Why arch curvature affects arch resistance
Toward a more rational approach in treating type B aortic dissection
Evaluating the best approach to treatment of aortic stenosis: The jury is still out  Glen B. Taksler, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Ryan R. Davies, MD  The Journal of Thoracic and Cardiovascular Surgery 
Proactive or reactive? Best approach to limb ischemia in peripheral venoarterial extracorporeal life support  Matthew C. Black, MD, Mark S. Slaughter,
Preoperative PFTs: The answer is blowing in the wind
Of mice and men… The Journal of Thoracic and Cardiovascular Surgery
Did you like Terminator 3 better than Terminator 2
Samuel Kim, MD  The Journal of Thoracic and Cardiovascular Surgery 
Michael T. Ingram, MS, David H. Wisner, MD, David T. Cooke, MD 
How do we follow up our patients
Carl L. Backer, MD, Bradley S. Marino, MD, MPP, MSCE 
Journal changes and initiatives
Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”
Edward Y. Chan, MD, Michael J. Reardon, MD 
Deciding how much to pay for effective care
Presentation transcript:

Evaluation of new Forcefield technology: Reducing platelet adhesion and cell coverage of pyrolytic carbon surfaces  Mark S. Slaughter, MD, Brian Pederson, BS, Joel D. Graham, MS, Michael A. Sobieski, RN, CCP, Steven C. Koenig, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 142, Issue 4, Pages 921-925 (October 2011) DOI: 10.1016/j.jtcvs.2011.01.012 Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Forcefield test system consisted of treated test unit, which comprised section of stainless steel tubing and 2 sections of pyrolytic carbon tubing, 2.5 cm long; electronic circuit board and electrodes connected to oscilloscope; and function generator. The Journal of Thoracic and Cardiovascular Surgery 2011 142, 921-925DOI: (10.1016/j.jtcvs.2011.01.012) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Platelet confluences on untreated section of pyrolytic carbon (Control) and treated section of pyrolytic carbon (Test) for 6 patients in study. Platelet confluence on control section ranged from 59% to 100% (mean 81.7% ± 24%); confluence on test section ranged from 1% to 7.2% (mean 3.3% ± 2.2%). The Journal of Thoracic and Cardiovascular Surgery 2011 142, 921-925DOI: (10.1016/j.jtcvs.2011.01.012) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 A, Appearance of untreated section of pyrolytic carbon (control). B, Appearance of treated section of pyrolytic carbon (test). The Journal of Thoracic and Cardiovascular Surgery 2011 142, 921-925DOI: (10.1016/j.jtcvs.2011.01.012) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Scanning electron microscopy (original magnification 1000×). A, Appearance of untreated section of pyrolytic carbon (control). B, Appearance of treated section of pyrolytic carbon (test). The Journal of Thoracic and Cardiovascular Surgery 2011 142, 921-925DOI: (10.1016/j.jtcvs.2011.01.012) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 Gel electrophoresis analyses of untreated and Forcefield-treated test sections of pyrolytic carbon after exposure to human blood. Dark bands between 50 and 75 kD indicate presence of albumin. It is hypothesized that albumin stabilizes charges on materials, preventing electric charge–related platelet interactions. At 50 kD, stimulation indicates possible change in composition of fibrinogen. The Journal of Thoracic and Cardiovascular Surgery 2011 142, 921-925DOI: (10.1016/j.jtcvs.2011.01.012) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions